Japanese encephalitis virus (JEV) is one of the most common pathogens of severe viral encephalitis, which is a severe threat to human health. Despite instability of the JEV genome in bacteria, many strategies have been developed to establish molecular clone systems of JEV, providing convenient tools for studying the virus life cycle and virus–host interactions. In this study, we adapted an In-Fusion enzyme-based in vitro recombination method to construct a reverse genetic system of JEV, thereby providing a rapid approach to introduce mutations into the structural genes. A truncated genome without the structural genes was constructed as the backbone, and the complementary segment containing the structural genes was recombined in vitro, which was then transfected directly into virus-permissive cells. The progeny of the infectious virus was successfully detected in the supernatant of the transfected cells, and showed an identical phenotype to its parental virus. To provide a proof-of-principle, the 12 conserved cysteine residues in the envelope (E) protein of JEV were respectively mutated using this approach, and all mutations resulted in a complete failure to generate infectious virus. However, a leucine-tophenylanine mutation at amino acid 107 of the E protein did not interfere with the production of the infectious virus. These results suggested that all 12 cysteines in the E protein are essential for the JEV life cycle. In summary, a novel reverse genetic system of JEV was established for rapidly introducing mutations into structural genes, which will serve as a useful tool for functional studies.
Allison SL, Schalich J, Stiasny K, Mandl CW, Heinz FX. 2001. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol, 75: 4268–4275.
Aubry F, Nougairede A, de Fabritus L, Querat G, Gould EA, de Lamballerie X. 2014. Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons. J Gen Virol, 95: 2462–2467.
Carleton M, Brown DT. 1996. Disulfide bridge-mediated folding of Sindbis virus glycoproteins. J Virol, 70: 5541–5547.
Chambers TJ, Hahn CS, Galler R, Rice CM. 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol, 44: 649–688.
Du R, Yin F, Wang M, Hu Z, Wang H, Deng F. 2015. Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus. J Gen Virol, 96: 1006–1014.
Fenouillet E, Lavillette D, Loureiro S, Krashias G, Maurin G, Cosset FL, Jones IM, Barbouche R. 2008. Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity. J Biol Chem, 283: 26340–26348.
Ghosh D, Basu A. 2009. Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis, 3: e437.
Li XD, Li XF, Ye HQ, Deng CL, Ye Q, Shan C, Shang BD, Xu LL, Li SH, Cao SB, Yuan ZM, Shi PY, Qin CF, Zhang B. 2014. Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A. J Gen Virol, 95: 806–815.
Lin TY, Dowd KA, Manhart CJ, Nelson S, Whitehead SS, Pierson TC. 2012. A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus. J Virol, 86: 3501–3512.
Luca VC, AbiMansour J, Nelson CA, Fremont DH. 2012. Crystal structure of the Japanese encephalitis virus envelope protein. J Virol, 86: 2337–2346.
Melian EB, Hinzman E, Nagasaki T, Firth AE, Wills NM, Nouwens AS, Blitvich BJ, Leung J, Funk A, Atkins JF, Hall R, Khromykh AA. 2010. NS1' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol, 84: 1641–1647.
Misra UK, Kalita J. 2010. Overview: Japanese encephalitis. Prog Neurobiol, 91: 108–120.
Mukhopadhyay S, Kuhn RJ, Rossmann MG. 2005. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol, 3: 13–22.
Orlinger KK, Hoenninger VM, Kofler RM, Mandl CW. 2006. Construction and mutagenesis of an artificial bicistronic tickborne encephalitis virus genome reveals an essential function of the second transmembrane region of protein e in flavivirus assembly. J Virol, 80: 12197–12208.
Pangerl K, Heinz FX, Stiasny K. 2011. Mutational analysis of the zippering reaction during flavivirus membrane fusion. J Virol, 85: 8495–8501.
Parrott MM, Sitarski SA, Arnold RJ, Picton LK, Hill RB, Mukhopadhyay S. 2009. Role of conserved cysteines in the alphavirus E3 protein. J Virol, 83: 2584–2591.
Polo S, Ketner G, Levis R, Falgout B. 1997. Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast. J Virol, 71: 5366–5374.
Pu SY, Wu RH, Tsai MH, Yang CC, Chang CM, Yueh A. 2014. A novel approach to propagate flavivirus infectious cDNA clones in bacteria by introducing tandem repeat sequences upstream of virus genome. J Gen Virol, 95: 1493–1503.
Pu SY, Wu RH, Yang CC, Jao TM, Tsai MH, Wang JC, Lin HM, Chao YS, Yueh A. 2011. Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. J Virol, 85: 2927–2941.
Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am J Hyg, 27: 493–497.
Solomon T, Winter PM. 2004. Neurovirulence and host factors in flavivirus encephalitis—evidence from clinical epidemiology. Arch Virol Suppl: 161–170.
Sumiyoshi H, Hoke CH, Trent DW. 1992. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol, 66: 5425–5431.
Sumiyoshi H, Tignor GH, Shope RE. 1995. Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J Infect Dis, 171: 1144–1151.
Ward R, Davidson AD. 2008. Reverse genetics and the study of dengue virus. Future virol., 3: 279–290.
Whitehurst CB, Soderblom EJ, West ML, Hernandez R, Goshe MB, Brown DT. 2007. Location and role of free cysteinyl residues in the Sindbis virus E1 and E2 glycoproteins. J Virol, 81: 6231–6240.
Wu KP, Wu CW, Tsao YP, Kuo TW, Lou YC, Lin CW, Wu SC, Cheng JW. 2003. Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem, 278: 46007–46013.
Yamshchikov V, Mishin V, Cominelli F. 2001. A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli. Virology, 281: 272–280.
Yun SI, Choi YJ, Song BH, Lee YM. 2009. 3' cis-acting elements that contribute to the competence and efficiency of Japanese encephalitis virus genome replication: functional importance of sequence duplications, deletions, and substitutions. J Virol, 83: 7909–7930.
Yun SI, Lee YM. 2014. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother, 10: 263–279.
Zhang F, Huang Q, Ma W, Jiang S, Fan Y, Zhang H. 2001. Amplification and cloning of the full-length genome of Japanese encephalitis virus by a novel long RT-PCR protocol in a cosmid vector. J Virol Methods, 96: 171–182.
Rights and permissions
About this article
Cite this article
Du, R., Wang, M., Hu, Z. et al. An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus. Virol. Sin. 30, 354–362 (2015). https://doi.org/10.1007/s12250-015-3623-2
- Japanese encephalitis virus (JEV)
- reverse genetic system
- in vitro recombination
- structural gene
- E protein